The preliminary consolidated results for 2020 confirm the Group’s growth capacity even in the current global public health emergency. The growth is mainly attributable to the increase in sales of highly innovative solutions, to the international expansion, and to the increase of private customers.
Selected the of counterparties that will proceed to the second phase of the process
Mid & Small in Milan - 22,23 November 2023
Management software and data governance for healthcare, digital tranformation is closer